Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and a Trustee of the Bios Centre for bioethics highlights an opportunity for mental health digital app developers.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today announced a new Community of Practice for Digital Mental Health Technologies, signalling a significant step in strengthening regulatory understanding, shared learning, and practical support for developers working in one of the fastest‑growing areas of UK medtech.
Published on the MHRA’s official blog, the announcement outlines a coordinated effort to help innovators navigate regulatory expectations, improve compliance, and accelerate safe, effective digital mental health solutions into clinical use. The initiative responds to increasing demand for clarity around evidence requirements, post‑market responsibilities, and the evolving regulatory landscape for software‑based and AI‑enabled mental health tools.
A sector‑wide forum for shared learning
The new community aims to bring together developers, clinicians, researchers, commissioners, and regulatory specialists to build a shared understanding of best practice. As digital mental health technologies expand — from therapeutic apps to AI‑supported assessment tools — the need for consistent, practical guidance has become more urgent.
Key objectives include:
- Supporting developers to interpret regulatory requirements and embed compliance earlier in product design.
- Identifying common challenges faced by innovators, particularly SMEs entering the mental health space.
- Sharing real‑world experience from organisations already navigating regulatory pathways.
- Strengthening dialogue between industry and regulators to ensure emerging technologies meet safety, performance, and evidence expectations.
For the wider medtech development community, this represents a valuable opportunity to engage directly with the regulator on issues that often determine whether promising technologies reach patients.
MHRA launches sector survey — developers encouraged to participate
To shape the community’s initial priorities, the MHRA has opened a survey seeking input from digital mental health technology developers and stakeholders across the medtech ecosystem. The survey explores current regulatory challenges, areas where clearer guidance is needed, and opportunities to improve compliance support.
The MHRA is encouraging broad participation to ensure the community reflects real‑world needs rather than top‑down assumptions. For developers, this is a direct route to influence future regulatory support and help shape a more predictable, transparent environment for innovation.
Access the survey
Readers can access and complete the survey here.
Digital mental health and wider medtech developers should take part in the survey and share the link within their organisations. A strong response will help ensure the new community delivers practical, meaningful support that accelerates safe, effective innovation for patients.
The Author used AI in preparing this article. Comments upon or questions about this article can be addressed to chris.whitehouse@whitehousecomms.com.
